FEMSelect
Modi'in
About FEMSelect
FEMSelect is making a lasting impact on women's health by delivering an innovative technology platform. It is the developer of EnPlace, a minimally invasive and mesh-free system for pelvic floor ligament fixation. Using EnPlace takes approximately 30 minutes. The patented delivery system enables the precise guidance, insertion, and deployment of the anchor unit. The anchor is designed to be introduced through the vaginal wall and secured to the pelvic floor ligament to provide stabilization. FEMSelect was founded in 2012 and is headquartered in Modi’in, Israel.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $13.3M
- Funding stage: Early Stage Venture
- Last round: Series B (May 2025)
- Website: femselect.com
- Phone: 1 215-940-8178
Industries & Categories
Health Care, Medical, Medical Device, Women's
Social Profiles
Canonical: https://fsome.com/organization/femselect-73304 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.